• Study on Secukinumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Non-Type 2 Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Estonia
  • Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Denmark Estonia France Germany +5
  • Study to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Hungary
  • Study on the Safety and Effects of Riociguat for Children Aged 6 to 17 with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy
  • Study on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Italy Spain
  • Study on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
  • Study on the Effects of Pitolisant for Children and Adolescents with Autism Spectrum Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Spain
  • Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    Bulgaria Czechia Germany Italy Poland Romania +1
  • Study on the Safety and Antitumor Effects of Vepdegestrant and Abemaciclib in Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Italy Spain
  • Study on the Safety of LSTA1 with Standard Care for Patients with Advanced Head and Neck Cancer or Cholangiocarcinoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    Spain

powered by